Here are the top 5 articles for the month of August.
Hi, this is Jaime Rosenberg for The American Journal of Managed Care® (AJMC®). Here are the top 5 articles for the month of August.
Number 5: Earlier this month, CMS announced that it will cover CAR T-cell therapies for Medicare beneficiaries nationwide. The agency approved the national coverage determination without some of the requirements that had some providers concerned.
Number 4: A review of published data found that the clinical manifestations of symptoms experienced by children and adolescents with narcolepsy can differ from those seen in adults, which creates barriers to a timely diagnosis.
Number 3: A study in this month’s issue of AJMC® concluded that California’s experience implementing a policy to address surprise medical billing demonstrates that out-of-network payment standards can influence payer­—provider bargaining leverage, affecting prices and network breadth.
Number 2: Researchers say they have discovered a potential new approach that can further suppress HIV infection. According to the researchers, the approach could complement antiretroviral therapy regimens in suppressing the silent virus these regimens struggle to combat.
Number 1: The American Heart Association released an advisory report saying that today’s prescription omega-3 fatty acid drugs effectively lower triglycerides and that patients should avoid treating themselves with fish oil supplements not approved by the FDA.
To read all of these articles and more, visit ajmc.com.
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen